Novartis AG company logo
Novartis AG logo

Novartis AG (NVS) Cash and Cash Equivalents

Annual Cash & Cash Equivalents

$11.59B$1.87B-13.87%

Summary

Current Value
As of today, NVS annual cash & cash equivalents is $11.59B, down -13.87% on
Historical Performance
NVS annual cash & cash equivalents is down -38.77% over the past 3 years, up +0.23% over the past 5 years
All-Time High Comparison
NVS annual cash & cash equivalents is currently -59.09% below its historical high of $28.33B set on
3-Year Low Comparison
NVS annual cash & cash equivalents is at its 3-year low
Sector Comparison
NVS annual cash & cash equivalents is higher than 99.83% of companies in Healthcare sector

Cash and Cash Equivalents Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

NVS Performance
MetricDateValue1Y3Y5Y15Y
Annual Cash & Cash Equivalents$11.59B-13.9%-38.8%+0.2%+42.2%
Quarterly Cash & Cash Equivalents$11.59B-13.9%-38.8%+0.2%+42.2%
Price$163.10+51.4%+86.4%+77.2%+225.4%
Annual Current Assets$30.46B+2.5%-17.5%+2.6%+13.9%
Annual Total Liabilities$69.02B+10.2%+10.7%-8.6%+28.6%
Annual Working Capital$3.18B+214.4%-61.5%+194.0%+56.6%
Annual Net Income$14.04B+17.6%+131.6%+73.9%+42.0%

Cash and Cash Equivalents Highs

NVS Annual Cash & Cash Equivalents Highs Comparison
PeriodHighDateCurrent
3Y$18.93BN/A-38.8%
5Y$28.33B-59.1%
All$28.33B-59.1%

Cash and Cash Equivalents Lows

NVS Annual Cash & Cash Equivalents Lows Comparison
PeriodLowDateCurrent
3Y$11.59Bat low
5Y$11.56BN/A+0.2%
All$5.08B+128.4%

Cash and Cash Equivalents History

YearValueChange
$11.59B-13.9%
$13.46B-6.7%
$14.43B-23.8%
$18.93B-33.2%
$28.33B+145.0%
$11.56B+1.0%
$11.45B-28.2%
$15.95B+68.2%
$9.49B+22.0%
$7.78B+42.8%
$5.45B-60.7%
$13.86B+50.3%
$9.22B+13.6%
$8.12B+60.0%
YearValueChange
$5.08B-37.7%
$8.15B-53.3%
$17.45B+185.3%
$6.12B-53.7%
$13.20B+65.9%
$7.96B-27.2%
$10.93B-21.5%
$13.93B+4.8%
$13.29B+8.6%
$12.24B-3.3%
$12.66B+24.2%
$10.20B-23.7%
$13.36B-

FAQ

  • What is the current annual cash & cash equivalents of NVS?

    As of today, NVS annual cash & cash equivalents is $11.59B

  • What is 1-year change in NVS annual cash & cash equivalents?

    NVS annual cash & cash equivalents is down -13.87% year-over-year

  • What is 3-year change in NVS annual cash & cash equivalents?

    NVS annual cash & cash equivalents is down -38.77% over the past 3 years

  • How far is NVS annual cash & cash equivalents from its all-time high?

    NVS annual cash & cash equivalents is currently -59.09% below its historical high of $28.33B set on December 31, 2021

  • How does NVS annual cash & cash equivalents rank versus sector peers?

    NVS annual cash & cash equivalents is higher than 99.83% of companies in Healthcare sector

  • When is NVS next annual earnings release?

    As of today, the next annual earnings release for NVS has not been scheduled

Cash and Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

Data Sources & References

  1. NVS Official Website www.novartis.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1114448/000111444826000007/0001114448-26-000007-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1114448/000111444826000004/0001114448-26-000004-index.htm
  4. NVS Profile on Yahoo Finance finance.yahoo.com/quote/NVS
  5. NVS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nvs